Research Article

Glomerular hyperfiltration in Yemeni children with sickle cell disease

Abdul-Wahab M Al-Saqladi* and Fatima E Al-Musawa

Published: 01/12/2021 | Volume 5 - Issue 1 | Pages: 001-007

Abstract

Background: Glomerular hyperfiltration (GH) is a common feature of sickle cell nephropathy (SCN) starting at infancy and represents an early marker of incipient glomerular injury and renal dysfunction.

Methods: This study aimed to determine the prevalence and correlates of GH among children (≤ 16 years) with sickle cell disease (SCD) at their steady state, recruited over 6 months at the Pediatric Outpatient Clinic in Al-Sadaqa General Teaching Hospital, Aden, Yemen. Glomerular filtration rate (eGFR) was estimated using the Schwartz formula. Data on clinical history, anthropometry, blood pressure (BP) and laboratory investigations were collected.

Results: Of 101 children (mean age 7.2 ± 3.9 years), 65 (64.4%) were males. The prevalence of GH was observed in 36 (35.6%) children, who were significantly older (10.7 ± 3.2 vs. 5.2 ± 2.7 years, p < 0.001) and had a lower fetal Hb level (5 ± 3.3 vs. 9 ± 7.1, p = 0.02). All children were normotensive, but hyperfiltrating children showed significantly higher systolic (97.2 ± 7.3 vs. 89.7 ± 5.2 mmHg) and diastolic pressure (55.1 ± 5.0 vs. 49 ± 4.3 mmHg) (all p < 0.001). Among evaluated children, 25.7% had hyperfiltration alone, whereas 9.9% had an associated microalbuminuria (MA), and no significant difference in eGFR between those with and without MA (158.4 ± 33.7 vs. 160.7 ± 29.8 ml/min/173m2, p = 0.84).

Conclusion: This study demonstrated a relatively high prevalence of GH in Yemeni children with SCD that increased with age. Recognition of hyperfiltration and other early markers of nephropathy in this population could help to develop renal protective strategies to prevent progressive loss of kidney function.

Read Full Article HTML DOI: 10.29328/journal.jcn.1001065 Cite this Article

References

  1. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013; 381: 142-151. PubMed: https://pubmed.ncbi.nlm.nih.gov/23103089/
  2. Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, et al. Sickle cell nephropathy in the pediatric population. Blood Purification. 2019; 47: 205-213. PubMed: https://pubmed.ncbi.nlm.nih.gov/30517931/
  3. Belisario AR, da Silva AA, Silva CV, de Souza LM, Wakabayashi EA, et al. Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients. Biomark Med. 2019; 13: 967-987. PubMed: https://pubmed.ncbi.nlm.nih.gov/31390894/
  4. Hariri E, Mansour A, El Alam A, Daaboul Y, Korjian S, et al. Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment. Int Urol Nephrol. 2018; 50: 1075-1083. PubMed: https://pubmed.ncbi.nlm.nih.gov/29383580/
  5. Naik RP, Derebail VK. The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait. Expert Rev Hematol. 2017; 10: 1087-1094. PubMed: https://pubmed.ncbi.nlm.nih.gov/29048948/
  6. Nath KA, Hebbel RP. Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol. 2015; 11: 161-171. PubMed: https://pubmed.ncbi.nlm.nih.gov/25668001/
  7. Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr Nephrol. 2011; 26: 1285-1290. PubMed: https://pubmed.ncbi.nlm.nih.gov/21559933/
  8. Hirschberg R. Glomerular hyperfiltration in sickle cell disease. Clin J Am Soc Nephrol. 2010; 5: 748-745. PubMed: https://pubmed.ncbi.nlm.nih.gov/20299367/
  9. Aloni MN, Ngiyulu RM, Gini-Ehungu JL, Nsibu CN, et al. Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings. PLoS One. 2014; 9: e96561. PubMed: https://pubmed.ncbi.nlm.nih.gov/24810610/
  10. Bodas P, Huang A, O’Riordan MA, Sedor JR, Dell KM. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease–a cross sectional review. BMC nephrology. 2013; 14: 237-243. PubMed: https://pubmed.ncbi.nlm.nih.gov/24168027/
  11. Marouf R, Mojiminiyi O, Abdella N, Kortom M, Al Wazzan H. Comparison of renal function markers in Kuwaiti patients with sickle cell disease. J Clin Pathol. 2006; 59: 345-351. PubMed: https://pubmed.ncbi.nlm.nih.gov/16567469/
  12. Haymann J-P, Stankovic K, Levy P, Avellino V, Tharaux P-L, et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol. 2010; 5: 756-761. PubMed: https://pubmed.ncbi.nlm.nih.gov/20185605/
  13. Lebensburger JD, Aban I, Pernell B, Kasztan M, Feig DI, et al. Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy. Am J Hematol. 2019; 94: 417-423. PubMed: https://pubmed.ncbi.nlm.nih.gov/30592084/
  14. Aloni MN, Ngiyulu RM, Ekulu PM, Mbutiwi FI, Makulo JR, et al. Glomerular hyperfiltration is strongly correlated with age in Congolese children with sickle cell anaemia. Acta Paediatr. 2017; 106: 819-824. PubMed: https://pubmed.ncbi.nlm.nih.gov/28218952/
  15. Al-Musawa FE, Al-Saqladi AM. Prevalence and correlates of microalbuminuria in Yemeni children with sickle cell disease. Saudi J Kidney Dis Transpl. 2019; 30: 832-842. PubMed: https://pubmed.ncbi.nlm.nih.gov/31464240/
  16. Schmitt F, Martinez F, Brillet G, Giatras I, Choukroun G, et al. Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis. 1998; 32: 208-214. PubMed: https://pubmed.ncbi.nlm.nih.gov/9708603/
  17. Alhwiesh A. An update on sickle cell nephropathy. Saudi J Kidney Dis Transp. 2014; 25: 249-265. PubMed: https://pubmed.ncbi.nlm.nih.gov/24625990/
  18. Zahr RS, Yee ME, Weaver J, Twombley K, Matar RB, et al. Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol. 2019; 34: 1435-1445. PubMed: https://pubmed.ncbi.nlm.nih.gov/30945006/
  19. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997; 102: 171-177. PubMed: https://pubmed.ncbi.nlm.nih.gov/9217567/
  20. Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009; 4: 1832-1843. PubMed: https://pubmed.ncbi.nlm.nih.gov/19820136/
  21. Piepsz A, Tondeur M, Ham H. Revisiting normal 51 Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging. 2006; 33: 1477-1482.
  22. Paula RPd, Nascimento AF, Sousa SMB, Bastos PRV, Barbosa AAL. Glomerular filtration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC. Rev Bras Hematol Hemoter. 2013; 35: 349-351. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832316/
  23. Alvarez O, Miller ST, Wang WC, Luo Z, McCarville MB, et al. Effect of hydroxyurea treatment on renal function parameters: results from the multicenter placebo controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatr Blood Cancer. 2012; 59: 668-674. PubMed: https://pubmed.ncbi.nlm.nih.gov/22294512/
  24. Ocheke I, Mohamed S, Okpe E, Bode-Thomas F, McCullouch M. Microalbuminuria risks and glomerular filtration in children with sickle cell anaemia in Nigeria. Ital J Pediatr. 2019; 45: 143-148. PubMed: https://pubmed.ncbi.nlm.nih.gov/31718702/
  25. Ware RE, Rees RC, Sarnaik SA, Iyer RV, Alvarez OA, et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr. 2010; 156: 66-70. e61. PubMed: https://pubmed.ncbi.nlm.nih.gov/19880138/
  26. Wigfall DR, Ware RE, Burchinal MR, Kinney TR, Foreman JW. Prevelance and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr. 2000; 136: 749-753. PubMed: https://pubmed.ncbi.nlm.nih.gov/10839871/
  27. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol. 2008; 83: 15-18. PubMed: https://pubmed.ncbi.nlm.nih.gov/17696198/
  28. Pikilidou M, Yavropoulou M, Antoniou M, Papakonstantinou E, Pantelidou D, et al. Arterial Stiffness and Peripheral and Central Blood Pressure in Patients With Sickle Cell Disease. J Clin Hypertens (Greenwich). 2015; 17: 726-731. PubMed: https://pubmed.ncbi.nlm.nih.gov/25991400/
  29. Novelli EM, Hildesheim M, Rosano C, Vanderpool R, Simon M, et al. Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One. 2014; 9: e114309. PubMed: https://pubmed.ncbi.nlm.nih.gov/25478953/
  30. Nnaji UM, Ogoke CC, Okafor HU, Achigbu KI. Sickle Cell Nephropathy and Associated Factors among Asymptomatic Children with Sickle Cell Anaemia. Int J Pediatr. 2020; 2020: 1286432. PubMed: https://pubmed.ncbi.nlm.nih.gov/32908550/
  31. Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, et al. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am J Hematol. 2013; 88: 116-119. PubMed: https://pubmed.ncbi.nlm.nih.gov/23255310/
  32. Al-Saqladi AM. Acute Kidney Injury: New Definitions and Beyond. J Nephrol Therapeut. 2016; 06: 1-4.
  33. King L, MooSang M, Miller M, Reid M. Prevalence and predictors of microalbuminuria in Jamaican children with sickle cell disease. Arch Dis Child. 2011; 96: 1135-1139. PubMed: https://pubmed.ncbi.nlm.nih.gov/21965808/